Abstract N 6-methyladenosine (m6A) modification is a kind of RNA modification in which
methylation occurs at the sixth N position in adenosine in RNA, which can occur in various …

Introduction Vascular calcification (VC) which is the pathological mineral deposition in the
vascular system, predominantly at the intimal and medial layer of the vessel wall, is an …

Chronic kidney disease (CKD) is a prevalent pathological condition worldwide. Parathyroid
hormone (PTH) is an important index related to bone metabolism in CKD patients and has …

Background: Chronic kidney disease (CKD) is now globally recognized as a critical public
health concern. Vascular calcification (VC) represents a significant risk factor for …

Background Diabetic patients on haemodialysis have a higher risk of mortality than non-
diabetic patients. The aim of this COSMOS (Current management of secondary …

A multimodality approach has been proposed as an effective treatment for calciphylaxis in
patients with end-stage kidney disease. In this retrospective study, we report the cases of 12 …

Cardiovascular disease (CVD) is a leading cause of death in chronic kidney disease (CKD).
Hemodialysis is one of the main treatments for patients with end-stage kidney disease …

Chronic kidney disease mineral bone disorder (CKD-MBD) is a complex clinical syndrome
responsible for the accelerated cardiovascular mortality seen in individuals afflicted with …

The global derangement of mineral metabolism that accompanies chronic kidney disease
(CKD-MBD) is a major driver of the accelerated mortality for individuals with kidney disease …

Introduction: End-stage renal disease (ESRD) is a growing disease worldwide, including
Korea. This is an important condition that affects patient outcome. To provide optimal …